Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Two Arrested In Tokyo For Selling ¥170 Million Worth Of Botox Without Permission

This article was originally published in PharmAsia News

Executive Summary

Tokyo based drug importer Forclinic President Kim Tae-hyon and another worker were arrested July 31 for violating the Pharmaceutical Affairs Law and selling drugs containing botulinum toxin without permission. Imported from Hong Kong, the drug has not been approved in Japan. According to the authority, the company sold it to 180 clinics nationwide and the sales totaled ¥170 million within a year. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts